Literature DB >> 20303010

Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey.

Muradiye Nacak1, Ibrahim Nacak, Maruf Sanli, Mehtap Ozkur, Mehtap Pektaş, A Sükrü Aynacioğlu.   

Abstract

Angiotensin-converting enzyme (ACE) plays an important role in the physiological control of blood pressure and inflammation. We investigated an insertion/deletion (I/D) polymorphism of the gene for ACE in relation to cardiovascular, cerebrovascular, neurodegenerative, and inflammatory diseases. The purpose of the present study was to investigate a possible association between lung cancer and insertion/deletion polymorphism of the ACE gene. A total of 125 patients with lung cancer and 165 control subjects were enrolled in the present study. ACE I/D genotypes were determined by polymerase chain reaction. Allelic frequencies and genotype distribution of the ACE I/D polymorphism in the patient group were significantly different from control subjects (ACE II genotype 29.6 vs. 17.6%, P = 0.011; ACE I allele 49.6 vs. 39.4%, P =0.009). Our data suggest that the ACE I/D polymorphism could be a risk factor for patients with lung cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303010     DOI: 10.1016/j.cancergencyto.2009.11.019

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  RETRACTED: Association of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism With Lung Cancer Susceptibility.

Authors:  Xiao-Neng Mo; Ri-Wen Yang; Feng Zhang; Yu Dong; Zi-Wen Zhao
Journal:  Technol Cancer Res Treat       Date:  2016-06-23

Review 2.  Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysis.

Authors:  Kan Zhang; Dan Cheng; Lingling Yi; Huimin Shi; Guohua Zhen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis.

Authors:  Yonggang Zhang; Jie He; Yao Deng; Jie Zhang; Xiaobo Li; Zhangpeng Xiang; Honglang Huang; Can Tian; Jin Huang; Hong Fan
Journal:  BMC Med Genet       Date:  2011-12-12       Impact factor: 2.103

Review 4.  The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Authors:  Iphigenia Gintoni; Maria Adamopoulou; Christos Yapijakis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

5.  An updated meta-analysis on association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and cancer risk.

Authors:  Yuebing Xie; Chao You; Jing Chen
Journal:  Tumour Biol       Date:  2014-04-03

6.  Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population.

Authors:  Syeda Hafiza Benish Ali; Kashif Sardar Bangash; Abdur Rauf; Muhammad Younis; Khursheed Anwar; Raja Khurram; Muhammad Athar Khawaja; Maleeha Azam; Abid Ali Qureshi; Saeed Akhter; Lambertus A Kiemeney; Raheel Qamar
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

Review 7.  [Research progress of lung cancer on single nuleotide polymorphism].

Authors:  Feng Hua; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.